» Articles » PMID: 8543388

Differential Regulation of Breast Tumor Cell Proliferation by Stromal Fibroblasts of Various Breast Tissue Sources

Overview
Journal Int J Cancer
Specialty Oncology
Date 1996 Jan 3
PMID 8543388
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

A stromal fibroblast-mediated paracrine regulation of epithelial tumor cell proliferation and differentiation plays an important role in the development and progression of breast tumors. We have studied the paracrine growth regulation of various phenotypically different breast cancer cell lines using conditioned serum-free media (C-SFM) from primary breast fibroblasts. Fibroblast cultures were established from malignant primary tumors and adjacent normal breast tissue, benign fibroadenomas, cosmetic reduction mammoplasties and breast skin tissues. All fibroblast-conditioned media were shown to stimulate the proliferation of breast cancer cell lines. However, the C-SFM-induced MCF-7 proliferative response was shown to be significantly higher than the proliferative response observed with any of the other cell lines tested. More importantly, the MCF-7 proliferative response obtained with malignant tumor tissue fibroblast C-SFM was shown to be significantly higher than the response to C-SFM from paired (and unpaired) normal adjacent breast tissue fibroblasts. The MCF-7 proliferative response to fibroblast C-SFM from normal tissue (adjacent to the tumor) was further shown to be comparable to the MCF-7 response using benign or reduction mammoplastic tissue fibroblast C-SFM. In addition, we show that IGFs are only partly responsible for the observed proliferative effect of the C-SFMs, while EGF, TGF alpha and basic-FGF are shown not to be involved. We conclude that stromal fibroblasts can differentially regulate breast cancer cell proliferation. Both the fibroblast's tissue source as well as the target tumor cell's phenotype will determine the extent of the proliferative response.

Citing Articles

Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1-line tamoxifen therapy in breast cancer.

Uhr K, Sieuwerts A, de Weerd V, Smid M, Hammerl D, Foekens J Sci Rep. 2018; 8(1):9657.

PMID: 29941867 PMC: 6018428. DOI: 10.1038/s41598-018-27987-w.


Effects of phthalates on normal human breast cells co-cultured with different fibroblasts.

Chen F, Chien M, Chen H, Ng Y PLoS One. 2018; 13(6):e0199596.

PMID: 29940022 PMC: 6016934. DOI: 10.1371/journal.pone.0199596.


Advances in the development of improved animal-free models for use in breast cancer biomedical research.

Roberts S, Speirs V Biophys Rev. 2017; 9(4):321-327.

PMID: 28748520 PMC: 5578919. DOI: 10.1007/s12551-017-0276-4.


Differences in tumor stroma derived from irradiated versus non-irradiated fibroblasts in a co-culture model with head and neck squamous cell carcinoma.

Gehrke T, Scherzad A, Hackenberg S, Schendzielorz P, Hagen R, Kleinsasser N Oncol Lett. 2016; 12(5):3549-3554.

PMID: 27900035 PMC: 5103981. DOI: 10.3892/ol.2016.5076.


A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer.

Hosein A, Livingstone J, Buchanan M, Reid J, Hallett M, Basik M BMC Cancer. 2015; 15:130.

PMID: 25884794 PMC: 4369836. DOI: 10.1186/s12885-015-1117-0.